Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 3112 for “"FDA"”.

  1. Common FDA Audit Findings: How do you find them before the FDA does?

    … checks and balances, while conducting an audit, FDA has observed numerous violations by institutions, come an audit. In order for institutions and clinicians to keep their credibility, it’s crucial to identify where the mistakes are being made and how to correct them before the FDA finds them. …

    jhu Repository record for Common FDA Audit Findings: How do you find them before the FDA does? (opens in a new tab)

  2. Practical software testing for an FDA-regulated environment

    Unlike hardware, software does not degrade over time or frequency use. This is good for software. Also unlike hardware, software can be easily changed. This unique characteristic gives software much of its power, but is also responsible for possible failures in software applications. When software …

    texas Repository record for Practical software testing for an FDA-regulated environment (opens in a new tab)

  3. Just Drop My Body on the Steps of the FDA: Emotion & Activism at ACT UP’s “Seize Control of the FDA” Action

    The outbreak of AIDS politicized and radicalized the gay community in New York City, which is when ACT UP emerged. The anger and hopelessness felt by the gay community due to the government’s inaction was vigorously channeled towards activism and disruption, which in turn created visibility and …

    cuny-grad Repository record for Just Drop My Body on the Steps of the FDA: Emotion & Activism at ACT UP’s “Seize Control of the FDA” Action (opens in a new tab)

  4. Consumer Perceptions of FDA Front-of-Package Nutrition Labeling

    The U.S. Food and Drug Administration (FDA) proposed a front-of-package nutrition labeling (FOPL) rule in early 2025 to help consumers more quickly and easily compare the nutritional quality of packaged foods (U.S. Food and Drug Administration, 2025). FOPL is gaining attention as a way to encourage …

    arkansas Repository record for Consumer Perceptions of FDA Front-of-Package Nutrition Labeling (opens in a new tab)

  5. The FDA revolving door : evidence from new drug review

    … consequences of the revolving door between FDA reviewers and the pharmaceutical industry. The ex-ante incentives arise because regulatory agency employees are frequently hired by the industry they previously regulated. Anticipation of future industry employment could motivate FDA reviewers …

    msu Repository record for The FDA revolving door : evidence from new drug review (opens in a new tab)

  6. Demographic profiles of clinical research participants in FDA-approved NMEs

    … approved by the U.S. Food Drug Administration (FDA) for 2010 and 2020 to compare demographic representation. Demographic representation of trial participants for 61 FDA-approved NMEs for 2010 and 2020 were gathered; 21 NMEs were excluded from analysis. The trends in demographic representation in …

    emich Repository record for Demographic profiles of clinical research participants in FDA-approved NMEs (opens in a new tab)

  7. FDA Regulation Impact on Early Stage Medical Device Innovation in Academia

    … of meeting Food and Drug Administration (FDA) regulatory requirements. Regulations and standards are undoubtedly necessary to maintain the highest product safety levels, but it creates many obstacles. This paper will analyze how researchers involved with early-stage medical device …

    rit Repository record for FDA Regulation Impact on Early Stage Medical Device Innovation in Academia (opens in a new tab)

  8. Καταγραφή κατευθυντήριων οδηγιών GCP Διεθνών οργανισμών (FDA, EMA). Ομοιότητες και διαφορές

    … που πρέπει να ακολουθούν οι διεθνείς οργανισμοί FDA και EMA κατά τη συμμετοχή τους σε ενέργειες που αφορούν τις κλινικές μελέτες που διεξάγονται παγκοσμίως. Πρωταρχικό σκοπό των κλινικών ερευνών και της καταγραφής των οδηγιών Oρθής Κλινικής Πρακτικής συνιστά η διασφάλιση και η προστασία των …

    athens Repository record for Καταγραφή κατευθυντήριων οδηγιών GCP Διεθνών οργανισμών (FDA, EMA). Ομοιότητες και διαφορές (opens in a new tab)

  9. Investigating FDA-Approved Drugs for Treatment of Multidrug-Resistant Neisseria gonorrhoeae

    … is a promising approach. In this study, an FDA-approved drug library was screened, and 14 drugs were found to exhibit promising anti-gonococcal activity. Interestingly, three extremely potent and narrow-spectrum novel candidates, itraconazole, isavuconazole, and ravuconazole, are azole …

    vt Repository record for Investigating FDA-Approved Drugs for Treatment of Multidrug-Resistant Neisseria gonorrhoeae (opens in a new tab)

  10. An evaluation and comparison of current FDA-approved treatments for obesity

    … phentermine/ topiramate extended-release became FDA-approved for long-term treatment of obesity. Each drug acts on a specific part of the CNS to modulate appetite and cause decreased food intake in patients. Clinical trials conducted on these medications found phentermine/topiramate …

    bu Repository record for An evaluation and comparison of current FDA-approved treatments for obesity (opens in a new tab)

  11. In Silico Mining of a System Wide Transcriptional Profiling Database for Clinically Relevant Gene Modulation by FDA Approved or FDA Ready Agents; Validation of a Novel Translational Approach

    It has been recognized that small molecules can affect a substantial proportion of the human transcriptome in ways that are currently unknown and difficult to predict. Working with the Broad Institute, using their Connectivity Map database, we have worked to identify compounds anticipated to …

    ottawa-retro Repository record for In Silico Mining of a System Wide Transcriptional Profiling Database for Clinically Relevant Gene Modulation by FDA Approved or FDA Ready Agents; Validation of a Novel Translational Approach (opens in a new tab)

  12. The development of a course of study in FDA drug regulatory procedures

    … regulation by the Food and Drug Administration (FDA). A summarization of the history of the development of the Food and Drug Administration (FDA) and of pharmacy education reveals a lack of interface between the two. The necessity for the interface of pharmacy education and the agency which has …

    u-pacific Repository record for The development of a course of study in FDA drug regulatory procedures (opens in a new tab)

  13. Hybrid RANS-LES Hemolytic Power Law Modeling of the FDA Blood Pump

    … the K-ω SST model to four flow conditions of the FDA blood pump. Validation of all three turbulence models show good agreement with experimental pressure and velocity fields. Evaluation of turbulent kinetic energy fields for the hybrid models show 80-90+% of kinetic energy is resolved in the rotor …

    usf Repository record for Hybrid RANS-LES Hemolytic Power Law Modeling of the FDA Blood Pump (opens in a new tab)

  14. Characterizing FDA-Approved Drugs Targeting Staufen1 as Therapeutics Against Skeletal Muscle Atrophy

    … therapeutic strategies, we aimed to identify FDA-approved compounds capable of reducing STAU1 expression during atrophy. A high-throughput ELISA-based screen of 770 FDA-approved drugs was conducted in myoblasts to assess their ability to downregulate STAU1 protein levels. Using our established …

    ottawa-retro Repository record for Characterizing FDA-Approved Drugs Targeting Staufen1 as Therapeutics Against Skeletal Muscle Atrophy (opens in a new tab)

  15. Anwendung und Mitentwicklung von OpenVigil 2.1 und OpenVigil FDA bei klinischen Fragestellungen

    … von den Daten der Food and Drug Administration (FDA) stammen. OpenVigil 2.1 und OpenVigil FDA sind öffentlich zugängliche Anwendungstools für Pharmakovigilanzanalysen, mit denen sich einfache bis komplexe Anfragen zu Signalen für Arzneimittelinteraktionen stellen und berechnen lassen. Es erfolgte …

    cau-kiel Repository record for Anwendung und Mitentwicklung von OpenVigil 2.1 und OpenVigil FDA bei klinischen Fragestellungen (opens in a new tab)

  16. Development of New Anionic Cascades and Analysis of US FDA Drug Architectures

    … cascades, structural analysis of FDA-approved pharmaceuticals as well as book chapter contributions in highlighting synthetic contributions in oxirane and aziridine chemistry. Chapter 1 presents two-book chapter contributions made which highlight synthetic contributions made with …

    arizona-thes Repository record for Development of New Anionic Cascades and Analysis of US FDA Drug Architectures (opens in a new tab)

  17. Open Public Comment: The Role of Patient Advocates in FDA Advisory Committee Meetings

    … Advisory Committees make recommendations to the FDA, which are almost always followed by concurrent regulatory action, after examining data submitted by the applicant and hearing commentary from the public, including patient advocacy groups. Many advocacy groups focus on a single rare or orphan …

    penn Repository record for Open Public Comment: The Role of Patient Advocates in FDA Advisory Committee Meetings (opens in a new tab)

  18. Essays on Product Recall Strategies and Effectiveness in the FDA-Regulated Food Sector

    … strategies in the Food and Drug Administration (FDA) regulated food sector. These studies address operations and supply chain factors that influence recall effectiveness with two theoretically-based, empirical approaches. The first essay examines recall effectiveness as measured by time to …

    clemson Repository record for Essays on Product Recall Strategies and Effectiveness in the FDA-Regulated Food Sector (opens in a new tab)

  19. Impact of FDA advisories on smoking cessation for Veterans with chronic obstructive pulmonary disease

    … were hospitalized before versus after the first FDA advisory in February 2008. We estimated rate ratios using Poisson regression, stratified by the presence of any mental health disorder and adjusted for likely confounders of demographics and smoking related morbidity. Among 344 eligible …

    washington Repository record for Impact of FDA advisories on smoking cessation for Veterans with chronic obstructive pulmonary disease (opens in a new tab)

Page 1 of 156